drug
TSC-101
Phase 2updated 5mo agoby $TCRX TScan Therapeutics, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying TSC-101
News(2)
- TScan cuts 75% of workforce while shifting focus to solid tumor programTScan Therapeutics is looking for strategic partnerships for its heme and autoimmune programs while working to advance two in vivo T cell therapy candidates into investigational new drug–enabling s…biospace · 23d ago
- TScan axes 75% of workforce to make room for solid tumor programsTCR-T specialist TScan Therapeutics will reduce its workforce by 75% following the pause of its hematological and autoimmune programs.fiercebiotech · 24d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that